4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-028051
Chief Scientific Officer sold 27,265 shares at an average $41.56 ($1,133,212)
- Chief Scientific Officer acquired 27,265 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
10 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-04-20 | Exercise or conversion : show line 1 in the form | +11,685 | $6.32 | $73,849 | 81,045 | D |
| 2021-04-20 | Sale : show line 2 in the form | −8,685 | $40.24 | $349,484 | 72,360 | D |
| 2021-04-20 | Sale : show line 3 in the form | −3,000 | $41.35 | $124,050 | 69,360 | D |
| 2021-04-21 | Exercise or conversion : show line 4 in the form | +7,790 | $6.32 | $49,233 | 77,150 | D |
| 2021-04-21 | Sale : show line 5 in the form | −500 | $39.85 | $19,925 | 76,650 | D |
| 2021-04-21 | Sale : show line 6 in the form | −2,090 | $41.17 | $86,045 | 74,560 | D |
| 2021-04-21 | Sale : show line 7 in the form | −5,200 | $41.79 | $217,308 | 69,360 | D |
| 2021-04-22 | Exercise or conversion : show line 8 in the form | +7,790 | $6.32 | $49,233 | 77,150 | D |
| 2021-04-22 | Sale : show line 9 in the form | −4,280 | $42.85 | $183,398 | 72,870 | D |
| 2021-04-22 | Sale : show line 10 in the form | −3,510 | $43.59 | $153,001 | 69,360 | D |
| Open-market sales · 27,265 sh · avg $41.56 · $1,133,212 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-04-20 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −11,685 | 155,800 | D |
| 2021-04-21 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −7,790 | 148,010 | D |
| 2021-04-22 | Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) | −7,790 | 140,220 | D |
Loading xslF345X03/doc4.xml…